Omega-3 fatty acids and depression: from cellular mechanisms to clinical care

J Clin Psychiatry. 2011 Feb;72(2):258-9. doi: 10.4088/JCP.11ac06830.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / physiopathology
  • Bipolar Disorder / psychology
  • Brain / drug effects
  • Brain / physiopathology*
  • Clinical Trials as Topic
  • Depressive Disorder / drug therapy
  • Depressive Disorder / physiopathology*
  • Depressive Disorder / psychology
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / physiopathology
  • Depressive Disorder, Major / psychology
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / adverse effects
  • Docosahexaenoic Acids / physiology
  • Dose-Response Relationship, Drug
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / adverse effects
  • Eicosapentaenoic Acid / physiology
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / adverse effects
  • Fatty Acids, Omega-3 / physiology*
  • Female
  • Humans
  • Inflammation / drug therapy
  • Inflammation / physiopathology
  • Neurogenesis / drug effects
  • Neurogenesis / physiology
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Synaptic Membranes / drug effects
  • Synaptic Membranes / physiology
  • Treatment Outcome

Substances

  • Fatty Acids, Omega-3
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid